ICT

Utrecht is an innovative city with a modern digital infrastructure and an excellent ecosystem for ICT companies. Offering an inspiring environment with a strong network of leading educational institutes, knowledge centers and many ICT companies.

Many of the city’s employees work in the ICT sector. Both Utrecht University and the Hogeschool Utrecht educate many specialized innovative talents and driven young professionals every year. For this exact reason, companies like Capgemini, Oracle, Ordina, Conclusion and VodafoneZiggo chose Utrecht for their headquarters. The city has a large pool of students  (67.500) and educated workers. Thanks to the city’s central location and excellent accessibility, another eight million qualified workers can reach Utrecht within an hour.

Utrecht provides a variety of high quality incubators, such as Graduate Space, the Jaarbeurs Innovation Mile, Startup Utrecht and UtrechtInc.

Share on FacebookTweet about this on TwitterShare on LinkedInShare on Google+

Deze ICT-bedrijven vestigden zich in Utrecht dankzij UCIB

“We found an attractive home for the employees of two merging companies in a dynamic and inspiring setting, where customers and companies can experience directly who we are and what we do.”

Marieke Dekker, Executive Director External Affairs

Read more

“Utrecht is increasingly developing into ‘health valley’. It offers a productive base for collaboration, research and innovation. Also in the areas in which the St. Antonius Hospital is specialized. This is good news for patient care.”

Douwe Biesma, CEO St. Antonius Hospital Utrecht

Read more

“We have deliberately chosen to stay in Utrecht. The central location and accessibility, both by car and public transport, make the city the best place to have our headquarters.”

Emlyn van der Wal, Chief Operating Officer at ABN AMRO Lease

Read more

“Genmab regards Utrecht Science Park as a unique ecosystem, where innovation actively leads to breakthroughs in the development of new medicines.”

Yvo Graus, Vice President Pre-Clinical Operations at Genmab

Read more

Alle referenties